Log In
BCIQ
Print this Print this
 

Zafi2

  Manage Alerts
Collapse Summary General Information
Company Accolade Pharmaceuticals LLC
DescriptionTopical formulation of zafirlukast
Molecular Target
Mechanism of ActionNSAID; Leukotriene receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAllergic conjunctivitis
Indication DetailsTreat allergic conjunctivitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today